Dendritic cells fused with allogeneic hepatocellular carcinoma cell line compared with fused autologous tumor cells as hepatocellular carcinoma vaccines.
Jun 2010 - Hepatol. Res.; 40(5):1386-6346 [PMID:20374301]
[Yang JY] [Cao DY] [Ma LY] [Liu WC]

Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell line HepG2 and autologous tumor cells as potential cancer vaccines against hepatocellular carcinoma.
Aug 2009 - Cell. Immunol.; 259(1):1090-2163 [PMID:19545862]
[Cao DY] [Yang JY] [Yue SQ] [Tao KS] [Song ZS] [Wang DS] [Yang YL] [Dou KF]

alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Apr 2007 - Hum. Immunol.; 68(5):0198-8859 [PMID:17462500]
[Cao DY] [Yang JY] [Dou KF] [Ma LY] [Teng ZH]